Pfizer Inc. Faces Layoffs Due to Disinterest in PROTAC Inhibitor
SOURCENews reportView the filing ↗
What we know
Location: New York, NY, USA.
Department affected: Biotech Division.
Based on news reporting.
Summary
Pfizer Inc. has announced layoffs affecting approximately 200 employees in its biotech division due to a loss of interest in commercializing a PROTAC inhibitor. This decision comes as the company shifts its focus away from this specific project, which has led to a restructuring within the organization. The layoffs are expected to impact operations significantly, as the affected employees were integral to the development of this therapeutic approach. The company is navigating a challenging landscape in biotech, prompting these workforce reductions to realign its strategic priorities.
LayoffTalk has tracked 9 layoff events at Pfizer Inc. since April 2023, including 404 jobs documented in official WARN filings, with 5 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Pfizer Inc.
Recent tracked events at this company.
Recent layoffs in NY
Other companies with tracked events in the same state.